A concise profile of cervical cancer and its public-health context
Bloomberg reports a telehealth company has disclosed plans to sell already allowed compounds such as sermorelin and glutathione, which patients pursue for wellness benefits despite limited clinical evidence. The move underscores ongoing tensions between patient demand and scientific validation.
A wave of studies finds that AI analysis of mammograms can identify cardiovascular risks in women, including hypertension, coronary heart disease and stroke, alongside breast cancer screening. Researchers say mammograms could become a dual-purpose tool for early cardiovascular risk detection, prompting earlier intervention.
Experts from University College London and MHRA have said there is no credible evidence that ethylene oxide–sterilised swabs used in cervical screening endanger patients. The claim on social media about cancer risk has been debunked. Cervical cancer diagnoses in the UK remain around 3,000 annually, and screening uptake has fallen to 66% of eligible women as of 2024.
A regional health story examines patient experiences with fibroids and miscarriage care, highlighting barriers to sexual and reproductive health services and calls for improved information access and care standards.
Amref Health Africa has called for stronger domestic financing and primary healthcare, warning that declines in external aid risk weakening health systems. The Berlin World Health Summit is used to push reforms and outline plans for Africa Health Agenda International Conference 2027 in Kigali.
Polio infections have been confirmed in two children in Syria’s Mayadin area. Health authorities are expanding vaccination campaigns, increasing surveillance, and mobilising teams to vaccinate children who missed routine immunisations. A second vaccination round will be launched next week, with support from WHO and UNICEF, as efforts intensify to prevent further transmission.